The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.75
Bid: 23.00
Ask: 24.50
Change: 0.00 (0.00%)
Spread: 1.50 (6.522%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 24.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Tremor Nasdaq IPO underway; MGC's CannEpil in Ireland

Tue, 15th Jun 2021 20:28

(Alliance News) - The following is a round-up of updates by London-listed companies issued on Monday and not separately reported by Alliance News:

----------

Tritax EuroBox PLC - investor in continental European logistics real estate assets - Starts work on on the 93,931 square metre extension to its global distribution centre asset at Llica d'Amunt, Barcelona, which is let to fashion retailer Punto Fa SL, trading as Mango. Company is financing the construction of the extension at a yield on cost of 8.8%, for an estimated capital commitment of EUR31.5 million.

----------

Tremor International Ltd - Tel Aviv-based advertising technology - Launches initial public offering on Nasdaq Global Market in New York of 6.8 million American depositary shares, representing an aggregate of 13.5 million shares. Each ADS represents two ordinary shares of Tremor. Notes last closing price of shares in London on Friday was GBP7.86. Closed at GBP8.00 on Tuesday.

----------

RTW Venture Fund Ltd - investment company focused on the life sciences sector - Participates in USD210 million Series B round in US-based privately held oncology company Umoja Biopharma Inc. "The proceeds from the Series B financing round are intended to enable Umoja to accelerate development of its pipeline of engineered immunotherapies and internal manufacturing capabilities," company explains.

----------

BATM Advanced Communications Ltd - Israel-based networking and medical technology company - Wins cyber security contract worth USD4.1 million, of which more than half will be delivered in the current year. "The contract has been awarded by the group's long-standing government defence department customer. The group will provide hardware and software as part of its network cyber security solution with delivery commencing immediately," company adds.

----------

Gresham House PLC - investor in smaller UK public companies - Court hearing for proposed capital reduction moved to June 29 from today, allowing notice of the hearing to be advertised for the period mandated by the Court.

----------

Sareum Holdings PLC - drug development company - Raises GBP1.5 million through subscription of 30.0 million shares at 4.9 pence each. Each subscriber will also be issued one five-year warrant, exercisable at the subscription price, for every three subscription shares issued. The net proceeds from the subscription will be used to progress the company's SDC-1801 and SDC-1802 TYK2/JAK1 inhibitor drug development programmes as well as for working capital purposes.

----------

Amino Technologies PLC - Cambridge-based broadcasting technology provider - Starts work with Hong Kong-based media firm PCCW Media to enable its Now TV video service. "Amino's software enables both PayTV and streaming services through an Android based user experience, including Netflix integration via Amino's Hailstorm Partnership with Netflix," company says. It adds: "Now TV is Hong Kong's leading Pay TV operator with the territory's largest subscriber base. PCCW plans to utilise Amino software to enhance its offering to deliver next generation viewing experiences, combining streaming services including Netflix within the service for the first time. The partnership utilises PCCW hardware with Amino's software solutions."

----------

Mirriad Advertising PLC - London-based company providing in-video advertising technology - Signs partnership with A+E Networks for in-content opportunities for brand partners. "In the fourth quarter 2020, both parties launched in collaboration a series of in-content activities within Lifetime holiday movies programming pillar, It's A Wonderful Lifetime. Following the success achieved during the collaboration, the A+E Networks team will begin to include in-content advertising for their agency and brand partners as part of their 2021-2022 Upfront opportunities," company explains.

----------

D4T4 Solutions PLC - Surrey, England-based IT services provider - Launches Celebrus Fraud Data Platform. Says will "support businesses in protecting their customers in real-time across all digital touchpoints." It adds: "This is the result of two years' design and development work and approximately GBP1.5 million of investment by the group and sees D4t4's initial launch into the large and growing market of fraud protection software, estimated to be worth currently USD18 billion per annum."

----------

IQGeo Group PLC - Cambridge, England-based geospatial software for telecom and utility network operators - Selected by the US Western Area Power Administration to support their electrical transmission line inspection process. "This new project will see the WAPA team using the IQGeo geospatial software in combination with its Inspection & Survey application. The software will be used by field teams conducting ground and aerial helicopter inspection patrols, and vegetation surveys," company adds.

----------

Condor Gold PLC - gold exploration and development in Nicaragua - Starts 1,700 metre infill geotechnical drilling programme within the permitted La India open pit in Nicaragua. Two diamond drill rigs have been deployed to expedite progress, company says. It adds: "The programme is anticipated to take 5 to 6 weeks to complete. The geotechnical drilling programme has been designed to achieve a feasibility level of design by SRK Consulting Ltd and will complement other ongoing feasibility study level work programmes already underway."

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Its cannabis derived epilepsy investigational medicinal product, CannEpil, has been added to the Primary Care Reimbursement Service in the Republic of Ireland as part of the Medicinal Cannabis Access Programme, making it free of charge for Irish patients prescribed the treatment under the MCAP. CannEpil is already being prescribed in Australia and the UK in the treatment epilepsy. Notes is saw best monthly revenue to date of more than AUD360,000, about USD276,000. Monthly sales revenue of over A$360,000 excludes all non-cannabinoid products.

----------

CIP Merchant Capital Ltd - AIM-listed closed-ended investment company incorporated in Guernsey - Buys further 150,000 shares in AIM-listed Ixico PLC for GBP120,000. Now holds interest in 3.4 million shares, or about 7.0%.

----------

Eastinco Mining & Exploration PLC - Musasa tantalum and tin metal project in Rwanda - Agrees terms and formally signs new joint venture agreement with an unnamed Rwandan entity to explore and develop mineral opportunities over an area covering 2,750 hectares in southern Rwanda on which the unnamed partner holds a license for the exploration and development of tantalum, niobium, tin and tungsten metal resources. Under the deal, Eastinco will create a new company, Kinunga Mining Ltd in Rwanda and hold 70% of its shares, with its partner holding the remaining 30%.

----------

Mosman Oil & Gas Ltd - New South Wales, Australia-based oil exploration, development and production company - Airborne gravity and gradiometry survey over EP 145, in the Amadeus Basin in the Northern Territory of Australia has now been approved by the relevant government department, company says. Work at EP 145 expects to start in the week commencing July 5.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
13 Jun 2019 15:49

Sareum Plans To Start Human Trials Of Two Drug Candidates In 2020

(Alliance News) - Sareum Holdings PLC on Thursday said it has been focusing on toxicology studies in its development of drug candidates SDC-1801 and SDC-1802 with a view to CONDUCT human trials in

Read more
3 Jun 2019 17:38

Sareum Notes Sierra Oncology's Positive Preliminary Results Of SRA737

LONDON (Alliance News) - Sareum Holdings PLC on Monday said it noted its licensee Sierra Oncology's webcast discussing clinical findings and possible next steps for SRA737, its oral checkpoint

Read more
3 Jun 2019 10:02

Sareum Reports Positive Data From Trials Of SRA737 In Advanced Cancer

LONDON (Alliance News) - Sareum Holdings PLC on Monday said that Sierra Oncology reported positive preliminary clinical data from two in-human studies of SRA737.Shares in the drug company a

Read more
4 Mar 2019 10:58

Sareum Interim Loss Deepens On Costs As Pipeline Continues Progress

LONDON (Alliance News) - Cancer drug discovery firm Sareum Holdings PLC said Monday its interim loss widened as costs rose, but it made progress with its key developmental programmes.For to

Read more
4 Mar 2019 08:26

Sareum's loss widens as development costs expand

(Sharecast News) - Sareum Holdings' shares dropped on Monday after the company reported a widened interim loss due to rising costs, though it stated progress had been made with key development programmes.

Read more
28 Feb 2019 14:33

Sareum flags potentially significant findings for SRA737

(Sharecast News) - Specialist small molecule drug development company Sareum Holdings announced on Thursday that Sierra Oncology, the licence holder advancing clinical cancer candidate SRA737, had reported that an abstract reporting preclinical data for SRA737 - its Chk1 inhibitor - plus low dose gemcitabine (LDG), in combination with immunotherapy, had been selected for a late-breaking oral presentation at the American Association of Cancer Research annual meeting.

Read more
11 Dec 2018 15:55

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 12 DecemberBlancco Technology GroupBellwayVolution Shopping REIT (re voluntary 13 Asian 14 to

Read more
30 Nov 2018 11:48

Sareum Reports Efficacy Data For Immunotherapy Combination With SRA737

LONDON (Alliance News) - Sareum Holdings PLC said Friday that Sierra Oncology Inc reported preclinical efficacy data for an immunotherapy combination with its SRA737 inhibitor in lung licences the

Read more
26 Oct 2018 09:20

Sareum Holdings Raises GBP850,000 Via Share Placing (ALLISS)

LONDON (Alliance News) - Sareum Holdings PLC said Friday it raised GBP850,000 via the issue of 130.8 million shares to fund the development of its lead cancer and autoimmune drugs.The drug

Read more
26 Oct 2018 08:38

Sareum raises £850,000 to fund cancer inhibitor

(Sharecast News) - Drug maker Sareum has raised £850,000 to progress the development programme of its cancer inhibitor TYK2/JAK1.

Read more
1 Oct 2018 11:30

Sareum Swings To Annual Loss After Prior Year Profit From Associates

LONDON (Alliance News) - Sareum Holdings PLC on Monday said it swung to an annual loss after reporting a substantial share of profit from associates the year before.Shares in Sareum were at

Read more
26 Sep 2018 15:20

Sareum Holdings selects cancer therapy development candidate

(Sharecast News) - Drug discovery and development company Sareum Holdings has made the formal selection of a development candidate from its TYK2 inhibitor programme to advance through preclinical development as a potential new targeted therapy for certain cancers, it announced on Wednesday.

Read more
26 Sep 2018 14:05

Sareum Selects Candidate To Develop Cancer Treatment

LONDON (Alliance News) - Sareum Holdings PLC said Wednesday that it has selected the SDC-1802 molecule from the TYK2 inhibitor programme for further development as potential treatment for certain

Read more
11 Sep 2018 13:28

Sareum Holdings Expects To Swing To GBP1.5 Million Annual Loss

LONDON (Alliance News) - Sareum Holdings PLC said Tuesday it expects to report a loss in its annual results as it progresses on its programmes in autoimmune diseases and cancer.The drug it

Read more
10 Sep 2018 11:52

Sareum Picks SDC-1801 For Development As Autoimmune Disease Treatment

LONDON (Alliance News) - Sareum Holdings PLC said Monday it will develop SDC-1801 as a possible treatment for autoimmune diseases.The molecule, SDC-1801, has been formally selected for is a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.